Side-by-side comparison of AI visibility scores, market position, and capabilities
AI wealth platform giving high-net-worth individuals access to private equity and pre-IPO investments with AI personalization; $4M from Giant Ventures and YC competing with Yieldstreet for alternative investment democratization.
goodfin is a Santa Monica-based AI-powered wealth management platform that provides high-net-worth individuals and startup founders with access to alternative investments — private equity, venture capital, and pre-IPO company shares — that are typically available only to institutional investors and ultra-high-net-worth family offices. Founded in 2022 and backed by Giant Ventures and Y Combinator with $4 million in seed funding, goodfin uses AI to provide personalized alternative investment recommendations, portfolio construction, and automated rebalancing that enables sophisticated investors to diversify beyond public markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.